These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22070180)

  • 1. Cognitive effects of risperidone in children with autism and irritable behavior.
    Aman MG; Hollway JA; McDougle CJ; Scahill L; Tierney E; McCracken JT; Arnold LE; Vitiello B; Ritz L; Gavaletz A; Cronin P; Swiezy N; Wheeler C; Koenig K; Ghuman JK; Posey DJ
    J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):227-36. PubMed ID: 18582177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
    Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.
    Vo LC; Snyder C; McCracken C; McDougle CJ; McCracken JT; Aman MG; Tierney E; Arnold LE; Levi D; Kelleman M; Carroll D; Morrissey J; Vitiello B; Scahill L
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):900-908. PubMed ID: 27726426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
    Eckert EM; Dominick KC; Pedapati EV; Wink LK; Shaffer RC; Andrews H; Choo TH; Chen C; Kaufmann WE; Tartaglia N; Berry-Kravis EM; Erickson CA
    J Autism Dev Disord; 2019 Nov; 49(11):4595-4602. PubMed ID: 31468273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Autism Spectrum Disorder in Children and Adolescents.
    DeFilippis M; Wagner KD
    Psychopharmacol Bull; 2016 Aug; 46(2):18-41. PubMed ID: 27738378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in blood is associated with risperidone response in children with autism spectrum disorders.
    Lit L; Sharp FR; Bertoglio K; Stamova B; Ander BP; Sossong AD; Hendren RL
    Pharmacogenomics J; 2012 Oct; 12(5):368-71. PubMed ID: 21647175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Peripheral Blood Levels of Cytokines With Autism Spectrum Disorder: A Meta-Analysis.
    Zhao H; Zhang H; Liu S; Luo W; Jiang Y; Gao J
    Front Psychiatry; 2021; 12():670200. PubMed ID: 34276441
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
    Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
    Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the Interplay Between Autism Spectrum Disorder and Comorbid Medical Conditions: An Integrative Review.
    Tye C; Runicles AK; Whitehouse AJO; Alvares GA
    Front Psychiatry; 2018; 9():751. PubMed ID: 30733689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
    Gładysz D; Krzywdzińska A; Hozyasz KK
    Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
    Prata J; Santos SG; Almeida MI; Coelho R; Barbosa MA
    J Neuroinflammation; 2017 Sep; 14(1):179. PubMed ID: 28870209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study.
    Pardo CA; Farmer CA; Thurm A; Shebl FM; Ilieva J; Kalra S; Swedo S
    Mol Autism; 2017; 8():1. PubMed ID: 28070266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.
    Fiorentino M; Sapone A; Senger S; Camhi SS; Kadzielski SM; Buie TM; Kelly DL; Cascella N; Fasano A
    Mol Autism; 2016; 7():49. PubMed ID: 27957319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders.
    Xu N; Li X; Zhong Y
    Mediators Inflamm; 2015; 2015():531518. PubMed ID: 25729218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in plasma cytokine levels during risperidone treatment in children with autism.
    Choi JE; Widjaja F; Careaga M; Bent S; Ashwood P; Hendren RL
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):586-9. PubMed ID: 24828014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.
    Tobiasova Z; van der Lingen KH; Scahill L; Leckman JF; Zhang Y; Chae W; McCracken JT; McDougle CJ; Vitiello B; Tierney E; Aman MG; Arnold LE; Katsovich L; Hoekstra PJ; Volkmar F; Bothwell AL; Kawikova I
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):555-64. PubMed ID: 22070180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.